Viela Bio reported consolidated earnings results for the fourth quarter and full year ended December 31, 2020. For the quarter, total net product revenue was $9.4 million. The company reported a net loss of $33.4 million, compared to a net loss of $11.6 million for the fourth quarter of 2019. For the year, total revenue was $11,652,000 against $50,000,000 a year ago. Loss from operations was $153,882,000 against $89,691,000 a year ago. Net loss was $150,668,000 against $86,429,000 a year ago. Net loss per share attributable to common stockholders—basic and diluted was $2.83 against $7.02 a year ago.